Home
About Us
Core Team
Development History
Corporate Culture
S&T
Research Areas
Technology Platforms
Research and Development
Marketed Products
R&D Products
R&D Pipeline
Academic Progress
Blog
Company News
Media Reports
Join Us
Post-Doctoral Center
Contact Us
[Case Study] Issue 334: Nilotinib Treatment for Nasopharyngeal Cancer
View details
→
[Case Study] Issue 333: The Use of Nimotuzumab in Conversion Therapy for Pancreatic Cancer
CCTV's "Finance & Business Live": Biotech Pharma Leverages Biotechnology to Enhance Public Health
[Doctors' Voices] Precision Treatment + Multidisciplinary Collaboration + Physician-Patient Partnership Achieve Long-Term Survival in Pancreatic Cancer
[Case Study by Xingsheng] Issue 332: Nilotinib Treatment for Laryngeal Cancer Combined with Esophageal Cancer
[Case Report] Issue 331: A Case Report on Nilotinib Combined with Chemotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma